Andre Schuh

Title: The Innovative Contributions of Andre Schuh

Introduction

Andre Schuh is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of medical science, particularly in the diagnosis and treatment of blood disorders. With a total of 3 patents to his name, Schuh's work has the potential to impact many lives.

Latest Patents

Schuh's latest patents focus on antibodies for the diagnosis and treatment of blood platelet alloimmune disorders. His research is based on the discovery of nucleotide and amino acid differences that distinguish the Gov and Govallelic forms of the membrane glycoprotein CD109. This discovery has led to the development of compositions and methods for determining the Gov genotype and phenotype of individuals. Furthermore, these innovations provide solutions for treating disorders associated with Gov alloantigen incompatibility, such as post-transfusion purpura, post-transfusion platelet refractoriness, and neonatal alloimmune thrombocytopenia. The two allelic forms of CD109 differ by a single amino acid, with the Govallelic form having Tyr at amino acid position 703, while the Govallelic form has Ser at the same position. This amino acid difference arises from a single change in the CD109 gene.

Career Highlights

Throughout his career, Andre Schuh has worked with various organizations, contributing his expertise to advance medical research. His innovative spirit and dedication to improving healthcare have made him a respected figure in his field.

Collaborations

Schuh has collaborated with notable professionals, including Willem Ouwehand and D Robert Sutherland. These partnerships have further enhanced his research and development efforts.

Conclusion

Andre Schuh's contributions to the field of medical science through his patents and collaborations highlight his commitment to innovation. His work in diagnosing and treating blood disorders showcases the importance of research in improving patient outcomes.